Gilman Hill Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-4,476
Closed -$233K – 174
2016
Q4
$233K Hold
4,476
– – 0.09% 158
2016
Q3
$216K Hold
4,476
– – 0.08% 166
2016
Q2
$248K Hold
4,476
– – 0.1% 141
2016
Q1
$239K Hold
4,476
– – 0.11% 142
2015
Q4
$230K Hold
4,476
– – 0.11% 144
2015
Q3
$202K Hold
4,476
– – 0.11% 145
2015
Q2
$207K Buy
+4,476
New +$196K 0.1% 162

Other funds holding PBH

Gilman Hill Asset Management's PBH Position: Q1 2017 in Review

Gilman Hill Asset Management sold out of Prestige Consumer Healthcare (PBH) in Q1 2017, closing a stake of 4,476 shares — an estimated $233K sold.

Gilman Hill Asset Management first reported a position in PBH in Q2 2015 and held it in 7 quarters. The position peaked at $248K in Q2 2016. 241 funds tracked by Wall St. Rank hold PBH as of Q1 2017.

  • Gilman Hill Asset Management reported no remaining Prestige Consumer Healthcare position as of Q1 2017 after selling out during the quarter.
  • Gilman Hill Asset Management sold 4,476 Prestige Consumer Healthcare shares in Q1 2017, an estimated $233K.
  • Gilman Hill Asset Management first reported a position in Prestige Consumer Healthcare in Q2 2015 and held it in 7 quarters.
  • Gilman Hill Asset Management's Prestige Consumer Healthcare position peaked at $248K in Q2 2016.
  • 241 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2017.

Based on Gilman Hill Asset Management's 13F filing for Q1 2017, filed 24 Apr 2017.